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Background: Although the negative health consequences of the exposure to second hand tobacco smoke during
childhood are already known, evidence on the economic consequences is still rare. The aim of this study was to
estimate excess healthcare costs of exposure to tobacco smoke in German children.
Methods: The study is based on data from two birth cohort studies of 3,518 children aged 9-11 years with
information on healthcare utilisation and tobacco smoke exposure: the GINIplus study (German Infant Study On The
Influence Of Nutrition Intervention Plus Environmental And Genetic Influences On Allergy Development) and the
LISAplus study (Influence of Life-Style Factors On The Development Of The Immune System And Allergies In East
And West Germany Plus The Influence Of Traffic Emissions And Genetics). Direct medical costs were estimated
using a bottom-up approach (base year 2007). We investigated the impact of tobacco smoke exposure in different
environments on the main components of direct healthcare costs using descriptive analysis and a multivariate
two-step regression analysis.
Results: Descriptive analysis showed that average annual medical costs (physician visits, physical therapy and
hospital treatment) were considerably higher for children exposed to second-hand tobacco smoke at home
(indoors or on patio/balcony) compared with those who were not exposed. Regression analysis confirmed these
descriptive trends: the odds of positive costs and the amount of total costs are significantly elevated for children
exposed to tobacco smoke at home after adjusting for confounding variables. Combining the two steps of the
regression model shows smoking attributable total costs per child exposed at home of €87 [10–165] (patio/balcony)
and €144 [6–305] (indoors) compared to those with no exposure. Children not exposed at home but in other
places showed only a small, but not significant, difference in total costs compared to those with no exposure.
Conclusions: This study shows adverse economic consequences of second-hand smoke in children depending on
proximity of exposure. Tobacco smoke exposure seems to affect healthcare utilisation in children who are not only
exposed to smoke indoors but also if parents reported exclusively smoking on patio or balcony. Preventing children
from exposure to second-hand tobacco smoke might thus be desirable not only from a health but also from an
economic perspective.* Correspondence: wenig@bwl.lmu.de
1Helmholtz Zentrum München, German Research Center for Environmental
Health, Institute of Health Economics and Health Care Management,
Member of the German Center for Lung Research, Neuherberg, Germany
2Ludwig-Maximilians-Universität München, Munich School of Management -
Institute of Health Economics and Health Care Management and Munich
Center of Health Sciences, Munich, Germany
Full list of author information is available at the end of the article
© 2012 Batscheider et al.; licensee BioMed Ce
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Batscheider et al. BMC Health Services Research 2012, 12:344 Page 2 of 11
http://www.biomedcentral.com/1472-6963/12/344Background
In 2003, active smoking was estimated to result in
114,647 deaths in Germany, over 1.5 million years of
life lost and 21 billion € of costs in terms of medical
care and production losses [1]. The German Cancer
Research Center estimated that in 2005 more than 8
million children in Germany lived in households with
at least one smoker, and about two-thirds of all chil-
dren aged 6-13 years [2], although the overall smoking
prevalence in the German adult population was
reported to be ‘only’ 29.9% in 2008/2009, depending on
age, sex and level of education [3]. The detrimental
consequences of second-hand smoke are already known
[4-7]. In children, second-hand smoke can lead to
respiratory diseases like chronic cough or asthma
[8-11]. For children whose parents smoke, second-hand
smoke was found to double the risk of otitis media
[12] and increase the risk of sudden infant death syn-
drome two- to fourfold [13,14].
People exposed to second-hand smoke inhale the
same damaging substances as active smokers. For chil-
dren below the age of 3 years, exposure to tobacco
smoke increases the amount of cotinine residues in
urine, even if parents only smoke on balconies, patios
and in gardens [15,16].
In addition to the health consequences of second-hand
smoke exposure during childhood, a major concern is
the related economic burden. International studies on
the impact of second-hand smoke exposure during
childhood on healthcare utilisation and costs are am-
biguous. Previous studies have focused on different age
groups, and used different methodologies concerning
cost measurement and included components, as well as
varying definitions of smoke exposure, so are not dir-
ectly comparable. A Norwegian study reported a signifi-
cant positive relationship between number of physician
visits and smoke exposure in 15-year-olds [17]. The
results of a US study in children under 12 years of age
generally indicate a negative effect of a child’s exposure
on the odds of any healthcare use but a positive effect
on respiratory expenses as well as higher expenses
among those with no respiratory expenses. However, the
total effect of smoking at home on medical expenditures
was not significant [18]. Other studies focused on costs
related to respiratory diseases [19-21] or on younger
children [19,22,23].
To date, German studies have focused on the behav-
ioural and health consequences of second-hand smoke
[24-29], whereas evidence regarding the economic im-
pact of second-hand smoke in Germany is rare [30,31].
Using a top-down approach, Thyrian et al. estimate that
more than 14,000 children are admitted to hospitals be-
cause their health is affected by exposure to tobacco
smoke in their homes [30].The aim of the present study was to estimate the ex-
cess healthcare costs of exposure to tobacco smoke over
12 months in children aged 9-11 based on two German
birth cohort studies, GINIplus and LISAplus.
Methods
Study design and population
Our analysis is based on data from the GINIplus
(German Infant Study On The Influence Of Nutrition
Intervention Plus Environmental And Genetic Influences
On Allergy Development) and LISAplus (Influence Of
Life-Style Factors On The Development Of The Immune
System And Allergies In East And West Germany Plus
The Influence Of Traffic Emissions And Genetics) stud-
ies, two ongoing population-based German birth cohorts
of healthy full-term neonates born between 1995 and
1999 in Munich, Wesel, Bad Honnef and Leipzig.
For the GINIplus study, 5,991 healthy full-term new-
borns were recruited from obstetric clinics in Munich
and Wesel between September 1995 and July 1998 [32].
Details of the intervention and control groups can be
found elsewhere [33]. In the 10-year follow-up, parents
of 3,287 children completed questionnaires, which
corresponds to a follow-up rate of 55% compared with
the baseline survey [34]. The LISAplus study is an on-
going population-based birth cohort study of unselected
newborns. A total of 3,097 healthy full-term newborns
were recruited from 14 obstetric clinics in Munich, Leip-
zig, Wesel and Bad Honnef between November 1997
and January 1999 [35]. In the 10-year follow-up, 1,762
children participated in the study (follow-up rate com-
pared with the baseline survey was 57%) [34]. Overall,
we find for both studies that children staying in the co-
hort up to the 10-year follow-up have a higher socio-
economic status at baseline compared to those dropping
out at some stage. For both cohorts, approval was
obtained from the respective local ethics committees
(Bavarian General Medical Council, University of Leip-
zig, and Medical Council of North-Rhine-Westphalia),
as well as written consent from the participants’ families.
Both studies had very similar study protocols, and
shared identical standard operating procedures since the
6-year follow-up [32,35].
Combined, the GINIplus and LISAplus cohorts offer
10-year follow-up data on 5,049 children [34]. For 3,642
children (72% of the 10-year follow-up), information on
healthcare utilisation is available. For 3,520 of these chil-
dren, information on current smoking-status is available.
Two children were excluded from analysis as they were
identified as highly influential due to extremely high
utilization. This exclusion was confirmed by the Walsh
test and by standardised DFBETA values after a model
including these observations was fit. This resulted in an
analysis population of 3,518 children.
Batscheider et al. BMC Health Services Research 2012, 12:344 Page 3 of 11
http://www.biomedcentral.com/1472-6963/12/344Definition of smoking status
Parents were asked if someone had smoked in their
homes during the last 12 months. Possible answer ca-
tegories were “daily or almost daily”, “at least once per
week”, “occasionally” and “never”. For those answering
“never”, we asked if someone had smoked on the bal-
cony or patio of their home or outside their home
environment. With this information, tobacco smoke ex-
posure was classified into four categories: “at home (in-
doors)”, “at home (patio/balcony)”, “not at home, but at
other places” and “no exposure”. As information on the
extent of smoke exposure was rather limited in the data,
it was not taken into account.
Covariates
We obtained information from both studies on socio-
demographic characteristics from self-administered
questionnaires filled in by parents. We used information
on parents’ education as a measure of the socio-
economic background of the children. Parental
education is defined as maximum completed years of
schooling of either of the parents, categorised as low
(<10 years), medium (=10 years) and high (>10 years).
Where information on parental education was missing
(in 0.4% of mothers and 2.0% of fathers), we imputed
the missing values with single imputation using the Mar-
kov Chain Monte Carlo (MCMC) method in SAS
(PROC MI). We then used the completed education
levels to impute missing income levels (9.8%) using the
logistic regression method within PROC MI.
Measurement and assessment of cost components
Direct medical costs were estimated using a bottom-up
approach, i.e. based on patient-level data on several
categories of utilisation of healthcare services. Parents
were asked to state number of physician visits (for
nine types of specialists), (physical) therapies (for seven
types of specialists) and number of hospital days
required by their child during the previous 12 months.
Prices were based on a national costing guideline from
the Working Group Methods in Health Economic
Evaluation (AG MEG) [36], where available, and on in-
formation from relevant organisations as well as a sur-
vey of market prices. All prices were denominated in
Euros and adjusted to the year 2007 following the AG
MEG recommendations. A more detailed description
on the methodology of monetary valuation is provided
elsewhere [34]. As there was no information available
on the reason for hospitalisation, we assessed the costs
of inpatient hospital treatment by multiplying the
number of days of the child’s stay by the mean costs
per hospital day.
In the rare cases where information on type of health-
care service and frequency of utilisation was missing, weapplied a three-step approach of missing value imput-
ation: first, if parents did not state whether or not a
specific type of service (physician/therapist/hospital) was
used, we imputed the use of a service (yes or no) with
single imputation using the MCMC method in SAS
(PROC MI). The information was missing in 16
(0.5%) cases for physician visits, in 22 (0.6%) cases for
therapist visits and in 19 (0.5%) cases for hospital stays.
Second, we used the resulting information to impute
whether a certain kind of specialist had been used (for
physicians and therapists only), again with single imput-
ation using the MCMC method. Third, we used the re-
gression method in PROC MI to impute the number of
specialist visits and hospital nights. We decided to use
this imputation approach, as in a complete case analysis
we would lose information for a total of 445 (12.6%)
children, where in many cases only information on
some cost category was incomplete. In particular, in the
case of hospital utilisation, where information on utilisa-
tion was almost complete, complete case analysis would
result in a disproportionate loss of information and an
imprecise estimation of average utilisation and costs. In
addition, cases with missing information were not dis-
tributed evenly between homes with and without smoke
exposure. In a sensitivity analysis using only complete
cases in the respective category, we found that results
barely changed.
Healthcare costs were assessed for all children and com-
pared between the different smoke exposure groups. As
the correlation between health problems and second hand
smoke exposure is not trivial and still not completely
understood, this excess cost approach is the best way to
capture all the differences between the analysed groups.
Statistical analysis
To account for non-normality of the cost data, we esti-
mated 95% confidence intervals (95% CIs) for differences
between groups, applying a non-parametric bootstrap
approach using the percentile method [37,38].
We analysed the effect of tobacco smoke exposure on
direct medical costs, composed of physician, therapist
and hospital costs, using a two-step approach, as a large
proportion of the children incurred no costs. These
zero-inflated data require an adequate statistical ap-
proach: first, we used a logistic model (LOGISTIC pro-
cedure in SAS) for the binary response variable to assess
the odds of generating costs in the respective category.
Second, we examined factors influencing the amount of
costs using a generalised linear model (GENMOD pro-
cedure in SAS) assuming an inverse Gaussian distribu-
tion of the response variable and a log-link function
[39,40]. In both steps, we controlled for sex, study
centre, parental education, household poverty status and
single parenthood. Recycled predictions were used to
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and costs as well as the total cost differences between
groups (smoking attributable total costs) across both
steps of the two-part model by combining the effect on
the probability of having positive costs and on the
amount of costs given costs are greater than zero [41].
95% confidence intervals (CI) for the adjusted cost dif-
ferences were estimated from 1000 bootstrap replica-
tions using the percentile method.
P-values of ≤5% were regarded as statistically signifi-
cant. Statistical analyses were performed with SAS soft-
ware (SAS Institute Inc., Cary, NC, USA, version 9.2).
Results
The socio-demographic characteristics of the study sam-









Net household income (€) Up to 1,500
1,500 - < 2,500
2,500 - < 3,500
3,500 and above
Poverty status of household
relative to median equivalence
income in Germany 2007
Up to 60% of median inco
60-100% of median incom
More than 100% of media
Education of the mother Low (<10 years)
Medium (=10 years)
High (>10 years)
Education of the father Low (<10 years)
Medium (=10 years)
High (>10 years)





Child’s exposure to tobacco smoke No exposure
Not at home, but at other
At home (patio/balcony)
At home (indoors)
SD: standard deviation.children were exposed to second hand tobacco smoke at
home (indoors or on patio/balcony).
Utilisation and base analysis of costs
Table 2 shows the number of children with service util-
isation, and unadjusted mean use of physicians, thera-
pists and hospitals for 12 months.
Average annual medical costs of physician visits, phys-
ical therapy and hospital treatment were estimated to be
€343 (313–380) per child. Costs were €286 (238–336)
for children having no exposure to smoke, €312 (250–
386) for children not exposed to smoke at home but at
other places, €346 (302–394) for children in homes
where smoking took only place on patio/balcony and
€449 (330–603) for children exposed to smoking at
home (indoors).GINIplus and LISAplus study
population analysed (n= 3,518)







































Physician visits (total) 2,979 (84.7%) 4.4 4.2
Paediatrician 1,955 (55.6%) 2.6 2.4 22.53
General practitioner 895 (25.4%) 2.2 1.6 18.87
Ophthalmologist 1,050 (29.9%) 1.4 0.9 30.80
Orthopaedist 538 (15.3%) 1.7 1.2 27.59
Ear, nose and throat specialist (ENT) 409 (11.6%) 1.9 1.7 29.29
Dermatologist 431 (12.3%) 2.2 3.2 18.40
Pulmonologist 101 (2.9%) 2.8 3.4 44.53
Other physician 346 (9.8%) 3.0 4.4 37.09
Emergency room 474 (13.5%) 1.3 0.7 44.62
Therapy (total) 891 (25.3%) 13.8 19.8
Alternative practitioner 217 (6.2%) 4.2 10.6 22.00
Physical therapy 196 (5.6%) 14.1 16.1 20.18
Speech therapy 145 (4.1%) 16.8 14.6 22.58
Psychotherapy 183 (5.2%) 12.7 15.4 55.94
Occupational therapy 98 (2.8%) 21.6 17.1 26.58
Homoeopathy 207 (5.9%) 3.0 2.6 First: 86.56;
Subsequent: 43.28
Other therapies 99 (2.8%) 11.8 15.3 31.33
Hospital (days) 193 (5.5%) 5.1 6.6 488.37
N=3,518.
* Unit costs according to a national costing guideline [36] updated to the base year 2007.
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associated with a higher total of physician, therapist and
hospital costs (p < 0.001), with the largest share of these
excess costs being caused by higher hospital costs.
Regression analysis
First, we analysed the impact of exposure to tobacco
smoke on the odds of incurring healthcare costs in the
fields of physician, therapist and hospital use. The results
are shown in Table 3. Smoke exposure at home, both in-
doors and on patios/balconies, resulted in higher odds of
physician use or any of the considered services
(p < 0.05). The impact of parental education and house-
hold’s relative income position, as well as sex of the
child, on the odds of using healthcare services was lim-
ited. Children of families with single parents used thera-
pists more likely (p < 0.001).
In a second step, we considered the influence of ex-
posure to tobacco smoke and confounding variables on
the amount of costs if the respective services were used.
Results are shown in Table 4. Evidence regarding the ef-
fect of exposure to tobacco smoke on healthcare costs is
mixed: whereas physician and therapist costs are not
influenced by exposure to tobacco smoke, hospital and
total costs were significantly higher (p < 0.05). Compared
with those not exposed, children who are exposed tosmoke inside their homes incurred significantly higher
hospital and total costs (p < 0.01), whereas for children
in homes where smoking took place on patios or balcon-
ies, only the sum of all cost categories was significantly
elevated (p < 0.05). As for the first step of the model, a
child’s sex, parental education and the household’s rela-
tive income position did not play an important role
regarding the amount of healthcare costs. Children of
single parents incurred significantly higher therapist,
hospital and total costs.
In summary, the odds of incurring healthcare costs by
children in homes where smoking was reported either
inside the home or on patios/balconies compared with
children not exposed to smoking was increased by 48%
and 35%, respectively. For those who incurred any
healthcare costs, costs were higher by 45% and 26%
respectively.
In a third step, we combined step 1 (use/non use) and
step 2 (costs of users), which allows for estimation of
adjusted mean costs for the whole sample. Figure 1 shows
these predicted mean costs for the single categories by
second-hand smoking status. Predicted total costs are
higher for the two groups of children with in-home expos-
ure to second-hand smoke (patio/balcony and indoors)
relative to those with either no in-home exposure (no ex-
posure or not at home, but at other places).
Table 3 Odds of using medical services
Parameter Physician use Therapist use Hospital use Physician, therapist or
hospital utilisation
Odds [95% CI] Odds [95% CI] Odds [95% CI] Odds [95% CI]
Intercept 4.77 [3.78–6.02] 0.36 [0.29–0.43] 0.04 [0.03–0.07] 5.90 [4.60–7.56]
Sex
Reference: Female 1.00 1.00 1.00 1.00
Male 1.03 [0.85–1.23] 1.16 [0.99–1.35] 0.92 [0.69–1.24] 1.08 [0.89–1.31]
Study centre
Ref: Munich 1.00 1.00 1.00 1.00
Leipzig 1.59 [1.09–2.30]* 0.80 [0.62–1.04] 1.48 [0.93–2.34] 1.37 [0.94–2.02]
Bad Honnef 1.12 [0.72–1.75] 0.67 [0.47–0.96]* 1.11 [0.58–2.12] 1.01 [0.63–1.60]
Wesel 0.70 [0.56–0.87]** 0.52 [0.42–0.63]*** 0.99 [0.69–1.43] 0.63 [0.50–0.79]***
Parental education
Ref: High (>10 years) 1.00 1.00 1.00 1.00
Low (<10 years) 1.30 [0.82–2.05] 0.69 [0.45–1.06] 1.16 [0.60–2.24] 1.24 [0.77–1.98]
Medium (=10 years) 1.14 [0.91–1.44] 1.05 [0.86–1.27] 1.08 [0.75–1.55] 1.12 [0.88–1.43]
Relative income position
Ref: > 100% of median income 1.00 1.00 1.00 1.00
0-60% of median income 0.88 [0.65–1.20] 0.87 [0.66–1.14] 1.19 [0.76–1.88] 0.90 [0.65–1.25]
60-100% of median income 0.82 [0.65–1.02] 1.07 [0.89–1.29] 0.81 [0.56–1.16] 0.79 [0.62–0.99]*
Single parenthood
Ref: No 1.00 1.00 1.00 1.00
Yes 1.11 [0.80–1.54] 1.53 [1.20–1.96]*** 1.01 [0.63–1.62] 1.11 [0.79–1.57]
Exposure to tobacco smoke
Ref: No exposure 1.00 1.00 1.00 1.00
Not at home, but at other places 1.27 [0.97–1.66] 0.98 [0.78–1.23] 1.25 [0.77–2.01] 1.26 [0.95–1.68]
At home (patio/balcony) 1.37 [1.07–1.75]* 1.13 [0.91–1.39] 1.52 [0.99–2.33] 1.35 [1.04–1.75]*
At home (indoors) 1.51 [1.11–2.06]** 1.06 [0.82–1.38] 1.60 [0.96–2.64] 1.48 [1.07–2.04]*
N=3,518.
Ref: Reference category.
Dependent variable: use of physicians/therapists/hospital/use of physicians, therapists and/or hospitals.
Assumptions: binomial distribution of the error terms, logit-link function.
***/**/*, significant at the 0.1%/1%/5% level.
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utable total costs per child with 95% confidence inter-
vals. It shows that the differences for the two in-home
exposure groups compared to “no exposure” are signifi-
cant: Children whose parents reported smoking at home
on the patio or balcony had excess costs of 87€ and chil-
dren whose parents reported smoking at home indoors
even 144€ compared to children who were not exposed
to second hand tobacco smoke. The difference between
the two in-home exposure groups (inside or on patios
and balconies) is meaningful in magnitude (57€) but not
statistically significant.
Discussion
This study investigated the differences in healthcare costs
for children exposed to different modes of tobacco smoke
using a bottom-up approach based on two German birthcohort studies. We found that children living in homes
where smoking was reported (either inside or on patios
and balconies) showed significantly higher medical costs
than children not exposed to smoke. For children who are
not exposed at home, but at other places, unadjusted med-
ical costs were also slightly higher; however, these differ-
ences are not significant. These descriptive findings were
confirmed by regression analysis. Thus, exposure to
tobacco smoke is shown to have an effect on direct health-
care costs independent from socio-economic status. As
the difference between the two in-home exposure groups
(inside or on patios and balconies) is not statistically sig-
nificant, attempts by parents who smoke to protect their
children by smoking only on balconies or in gardens ap-
pear to be ineffective.
Measuring the burden of second-hand smoke in terms
of implied healthcare costs rather than in terms of
Table 4 Amount of costs when medical services are used
Parameter Exp(Estimate) [95% CI]
Physician costs Therapist costs Hospital costs Sum of costs (physician,
therapist, hospital)
(N = 2,973) (N = 880) (N = 193) (N = 3,038)
Intercept 108.98 [99.10–119.83] 394.76 [295.91–526.63] 1778.92 [1298.02–2437.99] 302.84 [252.57–363.13]
Sex
Ref: Female 1.00 1.00 1.00 1.00
Male 1.05 [0.98–1.13] 1.26 [1.01–1.57]* 0.98 [0.78–1.24] 1.11 [0.95–1.29]
Study centre
Ref: Munich 1.00 1.00 1.00 1.00
Leipzig 1.06 [0.94–1.20] 0.76 [0.53–1.09] 1.21 [0.81–1.81] 1.26 [0.93–1.69]
Bad Honnef 0.99 [0.85–1.16] 0.78 [0.46–1.33] 0.91 [0.54–1.54] 0.82 [0.59–1.14]
Wesel 0.94 [0.86–1.03] 0.69 [0.52–0.91]** 0.96 [0.72–1.29] 0.71 [0.59–0.85]***
Parental education
Ref: High (>10 years) 1.00 1.00 1.00 1.00
Low (<10 years) 1.06 [0.90–1.26] 1.19 [0.60–2.35] 0.86 [0.51–1.45] 0.88 [0.63–1.23]
Medium (=10 years) 1.08 [0.99–1.18] 1.13 [0.85–1.50] 0.89 [0.67–1.18] 1.10 [0.91–1.33]
Relative income position
Ref: > 100% of median income 1.00 1.00 1.00 1.00
0-60% of median income 1.04 [0.92–1.17] 1.45 [0.92–2.29] 0.79 [0.56–1.11] 1.09 [0.86–1.39]
60-100% of median income 0.99 [0.91–1.08] 1.12 [0.87–1.43] 1.18 [0.87–1.61] 1.11 [0.94–1.33]
Single parenthood
Ref: No 1.00 1.00 1.00 1.00
Yes 1.11 [0.98–1.25] 1.55 [1.03–2.33]* 1.57 [1.02–2.43]* 1.61 [1.18–2.20]**
Exposure to tobacco smoke
Ref: No exposure 1.00 1.00 1.00 1.00
Not at home, but at other places 0.97 [0.87–1.08] 0.70 [0.50–0.97]* 1.33 [0.93–1.89] 1.02 [0.83–1.25]
At home (patio/balcony) 1.03 [0.93–1.14] 0.88 [0.65–1.20] 1.22 [0.88–1.71] 1.26 [1.02–1.54]*
At home (indoors) 0.92 [0.81–1.03] 1.00 [0.66–1.52] 1.83 [1.19–2.81]** 1.45 [1.11–1.89]**
Ref: Reference category.
Dependent variable: physician/therapist/hospital/sum of physician, therapist and hospital costs where respective costs >0.
Assumptions: inverse Gaussian distribution of the error terms, log-link function.
***/**/*, significant at the 0.1%/1%/5% level.
Figure 1 Predicted average adjusted costs by exposure to tobacco smoke.
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Not at home, but at other places 8€ [−67€ - 76€] 0.824
At home (patio/balcony) 87€ [10€ - 165€] 0.030
At home (indoors) 144€ [6€ - 305€] 0.034
Means, confidence intervals (CI) and p-values were derived from 1000
bootstrap replications of the recycled predictions using the percentile method.
Means correspond to differences in Figure 1.
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vantage that impacts can easily be aggregated across dif-
ferent diseases. To indicate an impact from exposure to
tobacco smoking, healthcare costs have to differ signifi-
cantly, which is a more conservative approach than
relying on a diagnostic label alone. Given that active
smoking significantly increases the risk of age-related
diseases such as heart and cardiovascular disease or can-
cer, one cannot expect comparable cost impacts of
second-hand smoke on children with a mean age of
10 years. As the correlation between health problems
and second hand smoke exposure in childhood is not
trivial and still not completely understood, the excess
cost approach is a possibility to capture all the diffe-
rences between the analysed groups, but it does not
allow for interpretation of causal pathways. The excess
cost approach used in this study is aimed at identifying
all excess healthcare utilisation due to either the condi-
tion under research itself (in this case smoke exposure)
or any other disorder related to this condition, i.e. its
consequences on health status. Thus, estimating the ex-
cess costs of exposure to second hand tobacco smoke in
a data set comprising current utilisation of health care
could potentially permit one to assess the total impact of
this exposure on costs of care.
In addition to these strengths there are several limita-
tions to this study. Both datasets provide information on
healthcare utilisation for the 10-year follow-up. Unfortu-
nately, it was only possible to include about 70% of the
10-year study participants due to missing data on health-
care utilisation or exposure to tobacco smoke. Like other
retrospective cost assessments, this study was prone to
recall error regarding utilisation of healthcare services.
As far as recall abilities of parents are not associated
with their child’s exposure to tobacco smoke, this should
only influence the estimated average costs, not the dif-
ferences between groups [42,43]. Additionally, our
results may not be fully representative for the German
population with regard to health-related as well as
socio-demographic characteristics. The fact that families
participating in the two birth cohorts show above-average education and income levels [34] may lead to an
underestimation of actual costs, but should not influence
cost differences substantially between the different
groups of exposure to tobacco smoke. In addition, all
study regions in this study are relatively urban. As in
more urban areas, the supply of healthcare may be more
extensive, this may lead to an overestimation of the ac-
tual healthcare costs. However, the comparison with the
probability of physician visits in the representative
KiGGS-Study [44] shows a similar picture for most com-
parable specialist groups.
Furthermore, the magnitude of healthcare costs
related to second hand smoke exposure might be under-
estimated due to the design of this study. Since children
with low birth weight, defined as birth weight below
2500 g, were not included in this study and low birth
weight might be a result of maternal smoking during
pregnancy, this study might have indirectly excluded
some children exposed to tobacco smoke in utero which
were shown to have an increased risk of hospital admis-
sion as infants in an earlier study by Adams et al. [45].
Moreover, it might be more likely that these children are
also exposed after birth. Moreover, the excess cost ap-
proach may overstate the actual impact of parental
smoking if there is unmeasured confounding that is
associated with both, parental smoking and parental in-
vestment in child health endowments, e.g. a healthy diet.
Although the overall smoking prevalence in the Ger-
man adult population was 29.9% in 2008/2009 [3], a
previous study found that about two-thirds of all chil-
dren aged 6–13 years were reported to live in a
household with at least one smoker [2]. One reason
for this gap might be that the smoking prevalence is
higher in younger adults (e.g., 37.9% in 18–29 year
olds) [3]. Furthermore, this gap might be explained by
a possible higher concentration of larger families in
lower-education smokers, as higher smoking preva-
lence was reported in people with lower levels of
school education [3]. However, in our study the per-
centage of children exposed to tobacco smoke at
home (indoors or on patio/balcony) was closer to one
half (55%).
As about 45% of children included in the cohorts at
birth did not participate in the 10-year follow-up, we are
unable to rule out non-response bias. The proportion of
people with high education was lower and the propor-
tion of mothers smoking during pregnancy was higher
in study dropouts than in participants. In addition, the
proportion of children being exposed to smoke during
their first year of life was higher in children who
dropped out. As information on healthcare use and ex-
posure to smoke was not available for all children at 10-
year follow-up, we performed additional non-response
analysis comparing these to the analysis group and
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These analyses are based on parent-reported tobacco
smoke exposure but not on biological markers, whereas
the validity is frequently criticised in relation to an
underreporting of the exposure. However, a sub-study of
these two birth cohorts showed a good agreement
between self-reported smoking at home and measured
residential air nicotine concentration as well as with
cotinine measurements in children’s urine [46]. In
addition, measurements of cotinine levels in children’s
urine are not very helpful when longer-term effects of
second hand smoke exposure will be assessed, because
of the short shelf-life of approximately 24 hours. We
consider a major bias of our results by the parent-
reported exposure to second hand smoke not as likely.
However, the effect on excess costs is less clear. If smo
king is underreported, cost of children not exposed may
be overestimated, resulting in an underestimation of ex-
cess costs. Furthermore, the role of the length of expos-
ure and transitions between exposure groups could not
be considered adequately and should be further
investigated.
Regarding estimation of direct healthcare costs, several
assumptions were necessary that may have caused over-
or underestimation of costs. We replaced missing values
for the number of physician and therapist visits as well
as hospital days using a multiple-step single imputation
technique. This may lead to smaller variances in the esti-
mates. We did not use multiple imputations, as this did
not seem feasible in our multi-step approach. We based
the assessment of cost components on the suggested
values published by the AG MEG [36], which were
updated to the base year 2007 to account for price
changes. This method has several limitations, especially
regarding price variation within healthcare sectors,
which is described in more detail in an earlier study
[34]. As the reasons for hospital stays were not available,
we used the same cost per day for all hospital stays. Ac-
tual reasons for hospitalisation might vary between
groups with different exposure to smoke, which might
influence the estimated cost differences. Moreover, we
based cost calculation on weighted mean prices for Ger-
many as these are assumed to reflect opportunity costs.
In infants, earlier studies found no significant associ-
ation between second-hand smoking and physician visits
[23,47]. Levy et al. detected no differences in children’s
overall Medicaid expenditures by presence of smokers in
the household [48]. One possible reason for this might
be selection bias. That is, families that expose their chil-
dren may also be less likely to take them to the doctor.
A lower use of health services in adult smokers was
found in earlier US studies [18,49]. Other studies, how-
ever, did find an association with higher utilisation ofhospitals [19,22]. Yet, we found that in older children of
about 10 years of age, second-hand smoke exposure is
associated with a higher probability of physician visits as
well as higher hospital costs. For the sum of the included
cost components, the odds of positive costs, as well as
the amount of costs, was significantly higher compared
with children who were not exposed to smoke. Similar
to our findings, van Reek et al. found increased likeli-
hood of visiting a physician for children who were
exposed to second-hand tobacco smoke 2 years before
assessment [17]. In a recently published study, Adams
et al. observed no significant association of maternal
smoking and admission to Neonatal Intensive Care
Unit but a positive effect on the length of stay of
exposed infants once admitted [50], which is in line
with our findings for hospital utilisation in older chil-
dren. Florence et al. report higher odds for respiratory
expenses in children exposed to second-hand smoke in
the USA [18]. In Germany, there is a lack of evidence
on the economic impact of second-hand smoke; how-
ever, Thyrian et al. estimate that tobacco smoke expo-
sure at home is responsible for more than 14,000 hos-
pital admissions in children. In line with our findings,
they also found a longer duration of stay using a top-
down approach [30]. The aim of the present study was
to fill the gap based on data from a large sample of
children in Germany. Cost estimates are based on a
bottom-up approach. In contrast to top-down studies,
which are based on aggregated data from administra-
tive statistics, this offers the possibility of adjusting the
estimates for a broader range of confounding variables.
Health insurance data might allow for more precise
cost estimations, but they don’t include information on
parents’ smoking status. As correlation between health
problems and smoke exposure is not trivial, the pre-
sented analyses are based on the excess cost approach,
attempting to capture all the differences between the
analysed groups of smoke exposure and minimising the
need for additional assumptions. Therefore, multivariate
statistical analyses did not include adjustments for
comorbidities [51].
Conclusions
This study indicates that children exposed to tobacco
smoke incur higher healthcare costs. Excess costs were
observed particularly for children exposed inside their
homes, but also those in homes where smoking oc-
curred on patios or balconies. These findings suggest
that efforts to prevent children’s exposure to smoke
should be increased considerably. As an important first
step, parents could be educated not to smoke indoors
at their home. However, children not exposed to
tobacco smoke at all show the lowest healthcare utilisa-
tion and costs. Therefore optimal prevention should
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ther increase awareness for this problem in the general
population. Public policies like non-smoking rules that
were lately introduced in Germany [52] as well as high
cigarette taxes [53] are first steps in this direction but
might not be enough. One possible approach could be
to target women who quit smoking during pregnancy
and prevent them from resuming to smoke. The
tobacco-free initiative of the WHO could provide a
framework for such efforts [54].Competing interests
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